Oct 12 (Reuters) - Spark Therapeutics Inc's experimental gene therapy for a rare form of blindness improves vision and should be approved, advisers to the Food and Drug Administration concluded on Thursday, paving the way for the first U.S. gene therapy for an inherited disease.


00


Reuters

Latest News

CNBC: A mobile payments app from US banks is less than a year old, but has surpassed PayPal's P2P volume

FOX: France to charge suspect in Spain attacks that killed 16

FOX: US Embassy in Jerusalem to open in May 2018

FOX: James Woods supports Brendan Fraser against Philip Berk

FOX: Long-lost Babe Ruth WWII-era radio interview found in obscure archive

CTV News: TD Bank stops allowing customers to use credit cards to buy cryptocurrency

Daily Mail: Pentagon makes recommendations to White House on...

Daily Mail: U.N. Security Council delays vote on Syria truce...

Daily Mail: The Latest: Trump sees 'long and beautiful' lines for...

Daily Mail: Clare Crawley's diamond engagement ring

Daily Mail: Prolific streaker Mark Roberts nude at Winter Olympics

Daily Mail: Dart Group boosted by strong leisure travel business

Daily Mail: LED lights on pedestrian crossings could prevent accidents

NBC New York: NY, NJ Among the Most Vain States, Study Reveals

CBS: Jennifer Lawrence says she dropped out of middle school

CTV News: Arcade Fire to perform, and get achievement award, at the Juno Awards

ABC: Volkswagen says earnings up more than 50 percent in 2017

ABC: Oscar Nominee Margot Robbie on why she chose to play Tonya Harding

CNBC: Maybe we’re setting the bar a bit too high for 2018: Strategist

CNBC: If you have to take a position, come down on the right side: NYT's Jim Stewart

CNBC: Chinese regulator seizes control of Anbang Insurance

BBC: Council tax

ABC: WATCH: Trump calls for making schools 'much harder targets for attackers'